November 12th 2024
A 12-week regimen showed significant reductions in wrinkle severity and pigment improvement.
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Six percent increase urged for dermatology funding
June 1st 2005Washington — Citing a new study that shows that skin disease "is more prevalent than anyone ever imagined," organizations representing dermatology have urged Congress to provide a 6 percent funding increase for research — more than three times the increase approved last year.
'Pre-biologics' not necessarily prehistoric
June 1st 2005Aat the recent annual meeting of the American Academy of Dermatology, there was a coronation of sorts. The biologic agents officially ascended to the status of treatment of choice for moderate-to-severe psoriasis. Several prominent dermatologists spoke on the subject and hailed these new agents as superior to old-fashioned remedies, which have now been dubbed "pre-biologics." Am I being too sensitive if I feel somewhat prehistoric when others label as pass? therapies that I use and upon which I routinely depend?
Growth in cosmetic procedures signals paradigm shift
May 1st 2005National report — With the number of cosmetic procedures performed nationally rising each year, the line between dermatology and plastic surgery continues to blur as dermatologists devote more time to cosmetic procedures and plastic surgeons embrace less invasive treatments.
Cigarette smoke impedes wound healing
May 1st 2005Riverside, Calif. — Fifty years after the negative effects of cigarette smoke first became broadly known, doctors are still discovering the magnitude of and mechanisms behind its toxic assault on the body. Dermatologists are particularly interested in discoveries over recent years that cigarette smoke results in premature aging of the skin and decreases blood flow to wound sites, resulting in retarded granulation tissue development and remodeling during wound healing and greater scarring.
Skin regeneration through growth hormone factors
May 1st 2005Tokyo — Growth factors offer seemingly endless potential to skin wound repair and regeneration, yet there are several questions surrounding those that are exogenously applied to acute or chronic skin wounds, according to Xiaobing Fu, M.D., professor, Wound Healing and Cell Biology Laboratory, Burns Institute, The General Hospital of PLA, Beijing, China.
Artificial skin could mimic normal skin
May 1st 2005Potsdam, N.Y. — Researchers at Clarkson University are working on a skin substitute that they hope one day will heal and function like normal skin. As such, physicians could use it successfully to treat large burns or areas of surgical reconstruction.
Going cosmetic? Start small—commit big
April 11th 2005New Orleans — The biggest mistake most dermatologists make when they decide to start a cosmetic dermatology practice is trying to jump into things too fast. That's the message Joel Schlessinger, M.D., a successful cosmetic dermatologist from Omaha, Neb., likes to share with his colleagues who are considering that move.
Multiple principles underlie safe, effective PIH tx
April 10th 2005San Diego — Post-inflammatory hyperpigmentation (PIH) is a common complaint among skin of color patients and one that is important to manage effectively because it can be a source of significant psychosocial distress, said Patricia Dunwell, M.D., at the Annual Meeting of the American Academy of Cosmetic Surgery (AACS).
Single session Botox safe, effective
April 1st 2005New Orleans — Botulinum toxin type A (Botox, Botox Cosmetic; Allergan) can be used safely and effectively in a range of doses to simultaneously treat a spectrum of upper facial rhytids in adult women, although use of a higher dose affords benefits for improved magnitude and durability of response without compromising safety, according to the results of a dose-comparison study presented by Alastair Carruthers, M.D., and Jean Carruthers, M.D., at the 63rd Annual Meeting of the American Academy of Dermatology (AAD).
Use of poly-L-lactic acid shows promise as treatment for lipodystrophic facial aging
April 1st 2005New Orleans — Initial clinical experience indicates injectable poly-L-lactic acid (Sculptra) can be used safely and effectively to achieve natural-appearing restoration of facial volume and contour in patients with age-related facial lipodystrophy, said Douglas Key, M.D., at the 63rd Annual Meeting of the American Academy of Dermatology (AAD) here.
Derm projects range of HA products will provide toolsfor lunchtime filling
April 1st 2005Boston — Although, for many patients, hyaluronic acid (HA) fillers have become the treatment of choice in the United States, Gary D. Monheit, M.D., says many questions remain: Can Hylaform (Inamed), Restylane (Q-Med) and Juvederm (LEA Derm) be improved to achieve more than a three- to six-month longevity? How will the fillers compare after more extensive head-to-head testing? And where will HA products ultimately fit in an armamentarium ranging from bovine collagen to polylactic acid?
New cosmetic laser technology emerges; noninvasive treatment rejuvenates skin
April 1st 2005New Orleans — A striking array of new, non-invasive cosmetic laser treatments and devices has been developed recently to help dermatologists rejuvenate skin and improve appearance. From class 2 products that treat cellulite to a variety of radiofrequency devices, the many options may leave physicians wondering which one to choose.
Alternative treatments for alopecia areata
April 1st 2005Florence — Alopecia areata is a disease with important aesthetic implications that may affect the patient psychologically and socially, and treatment can be challenging, according to Ana Kaminsky, M.D., Ph.D., professor of dermatology, School of Medicine, University of Buenos Aires, Argentina.
Vanity tax: Does it restrict choice?
April 1st 2005National report — A new precedent has been set in the cosmetic surgery industry, but it has nothing to do with surgical results. In September, New Jersey became the first state to enact a vanity tax on cosmetic surgery and Botox injections — a move that lawmakers elsewhere are now seeking to emulate, potentially leaving physicians and their patients at a loss.
Growth in cosmetic procedures signals shift
April 1st 2005National report — With the number of cosmetic procedures performed nationally rising, the line between dermatology and plastic surgery continues to blur as dermatologists devote more time to cosmetic procedures and plastic surgeons embrace less-invasive treatments.